UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

The Journal of infectious diseases, 2016-02, Vol.213 (3), p.411-422

2016

Volltextzugriff (PDF)

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Vaccine, 2013-01, Vol.31 (3), p.524-532

2013

Volltextzugriff (PDF)

Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus

International journal of molecular sciences, 2021-11, Vol.22 (21), p.12004

2021

Volltextzugriff (PDF)

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans

Journal of Virology, 2011-11, Vol.85 (21), p.10945-10954

2011

Volltextzugriff (PDF)

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

Journal of immunological methods, 2015-02, Vol.417, p.22-33

2015

Volltextzugriff (PDF)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

Immunity & ageing, 2017-04, Vol.14 (1), p.8-8, Article 8

2017

Volltextzugriff (PDF)

Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates

Microorganisms (Basel), 2024-06, Vol.12 (6), p.1177

2024

Volltextzugriff (PDF)

Immunological and Safety Considerations When Selecting the Dose Formulation of a Purified Inactivated Zika Virus Vaccine (PIZV)

Microorganisms (Basel), 2024-07, Vol.12 (7), p.1492

2024

Volltextzugriff (PDF)

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

Vaccine, 2017-06, Vol.35 (30), p.3749-3759

2017

Volltextzugriff (PDF)

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

Vaccine, 2016-04, Vol.34 (16), p.1927-1935

2016

Volltextzugriff (PDF)

Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System

The Journal of infectious diseases, 2023-05, Vol.227 (11), p.1282-1292

2023

Volltextzugriff (PDF)

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

Vaccine, 2013-09, Vol.31 (40), p.4305-4313

2013

Volltextzugriff (PDF)

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

Vaccine, 2012-03, Vol.30 (12), p.2098-2108

2012

Volltextzugriff (PDF)

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs

Vaccine, 2015-11, Vol.33 (47), p.6488-6492

2015

Volltextzugriff (PDF)

A Ballooned Beta-Logistic Model

Statistics in biopharmaceutical research, 2017-01, Vol.9 (1), p.98-106

2017

Volltextzugriff (PDF)

A new bounded log-linear regression model

Metrika, 2014-07, Vol.77 (5), p.695-720

2014

Volltextzugriff (PDF)

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study

Journal of acquired immune deficiency syndromes (1999), 2001-03, Vol.26 (3), p.236

2001

Volltextzugriff (PDF)

A Comparative Study of Statistical Methods to Assess Dilutional Similarity

Biopharm International, 2005-10, Vol.18 (10), p.60

Kpamegan, Eloi P

2005

Volltextzugriff (PDF)

Optimal designs for bivariate binary random variables in a bivariate treatment space

Kpamegan, Eloi Patrick

1997

Volltextzugriff (PDF)

D-Optimal Designs Given a Bivariate Probit Response Function

Lecture notes-monograph series, 1998-01, Vol.34, p.62-72

Eloi P. Kpamegan

1998

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(20)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates

Immunological and Safety Considerations When Selecting the Dose Formulation of a Purified Inactivated Zika Virus Vaccine (PIZV)

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement System

Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs

A Ballooned Beta-Logistic Model

A new bounded log-linear regression model

Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study

A Comparative Study of Statistical Methods to Assess Dilutional Similarity

Optimal designs for bivariate binary random variables in a bivariate treatment space

D-Optimal Designs Given a Bivariate Probit Response Function

Suchergebnisse filtern